Epicardial Ablation of Ischemic Ventricular Tachycardia

Area of Science:

• Cardiology
• Electrophysiology
• Cardiac Surgery

Background:

• Ischemic cardiomyopathy frequently causes ventricular arrhythmias, including life-threatening ventricular tachycardia (VT).
• Endocardial catheter ablation is a primary treatment for VT, reducing episodes and implantable defibrillator shocks.
• A significant portion of VT originating from post-infarction scar tissue is not amenable to endocardial ablation.

Purpose of the Study:

• To review the challenges and limitations of endocardial catheter ablation for ventricular arrhythmias in ischemic cardiomyopathy.
• To discuss the role of epicardial ablation in accessing difficult VT circuits.
• To highlight factors limiting ablation success and potential alternative approaches.

Main Methods:

• Review of current literature on catheter ablation techniques for ventricular arrhythmias.
• Analysis of anatomical and procedural factors influencing ablation success.
• Discussion of epicardial access strategies and their limitations.

Main Results:

• Endocardial ablation is effective but cannot reach all VT substrates in ischemic cardiomyopathy.
• Epicardial ablation offers access to some previously inaccessible VT circuits.
• Anatomical barriers (phrenic nerve, coronary arteries) and intramural circuits limit epicardial ablation success.
• Adhesions from prior surgery often require surgical pericardial access.

Conclusions:

• While endocardial ablation is valuable, a substantial number of VT cases in ischemic cardiomyopathy require consideration of epicardial or alternative approaches.
• Epicardial ablation expands treatment options but faces its own set of anatomical and technical challenges.
• Multidisciplinary approaches may be necessary for complex VT cases, especially in patients with prior cardiac surgery.